| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 235.24M | 111.92M | 66.40M | 44.71M | 22.59M |
| Gross Profit | 169.17M | 100.55M | 59.91M | 38.83M | 8.39M |
| EBITDA | 110.15M | 6.76M | 23.78M | 34.81M | 1.03M |
| Net Income | 36.53M | -23.96M | 9.52M | 31.68M | 997.41K |
Balance Sheet | |||||
| Total Assets | 915.92M | 874.16M | 331.83M | 59.09M | 1.84M |
| Cash, Cash Equivalents and Short-Term Investments | -384.62K | 131.94M | 27.84M | 30.05M | 102.42K |
| Total Debt | 411.18M | 385.91M | 141.74M | 28.33M | 1.05M |
| Total Liabilities | 478.70M | 450.87M | 167.76M | 30.95M | 1.07M |
| Stockholders Equity | 418.54M | 424.15M | 163.93M | 27.25M | 915.05K |
Cash Flow | |||||
| Free Cash Flow | -26.61M | -209.62M | -64.71M | 10.61M | 1.12M |
| Operating Cash Flow | -25.68M | -208.81M | -64.52M | 10.69M | 1.34M |
| Investing Cash Flow | -23.28M | -4.96M | 2.24M | -3.70M | -241.53K |
| Financing Cash Flow | -44.87M | 320.12M | 57.82M | 22.96M | -354.58K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $55.07M | 25.36 | 4.89% | 0.74% | 11.99% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $957.70M | 22.51 | 8.49% | ― | 91.78% | ― | |
62 Neutral | $3.85B | 11.12 | 8.60% | 1.54% | -1.61% | 15.79% | |
58 Neutral | $3.13B | 447.44 | 2.54% | ― | 1.41% | 150.35% | |
54 Neutral | $3.41B | 8.55 | 7.20% | ― | 27.71% | ― | |
52 Neutral | $241.94M | 8.25 | 4.93% | ― | -0.55% | -51.14% |
On March 12, 2026, Abacus Global Management reported that fourth quarter 2025 revenue rose 116% year over year to $71.9 million and full year 2025 revenue more than doubled to $235.2 million, driven largely by surging Life Solutions and Asset Management income. The company swung from a prior-year GAAP net loss to 2025 net income of $36.5 million, lifted adjusted net income 84% to $85.7 million and expanded adjusted EBITDA 115% to $132.6 million, while deploying $580.8 million of origination capital and growing policy originations 26%.
Management highlighted 11 consecutive quarters of earnings outperformance, ROE and ROIC above 20% and a fourth quarter adjusted EBITDA margin of 54%, underscoring the scalability of its alternative asset platform. Abacus also initiated a full-year 2026 adjusted net income outlook of $96 million to $104 million, approved its first annual dividend and a $20 million share repurchase program, moved its listing to the NYSE, completed the AccuQuote acquisition and announced a $52.9 million minority investment in Manning & Napier, collectively strengthening shareholder returns, broadening wealth and protection capabilities and reinforcing its long-term ambition to become a mid-cap manager with roughly $450 million in adjusted EBITDA at scale.
The most recent analyst rating on (ABX) stock is a Buy with a $13.50 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.
On January 30, 2026, Abacus Global Management announced that its board of directors had approved a $20 million share repurchase program, effective immediately and running through May 6, 2027, as part of its capital allocation strategy. The buyback, to be funded with cash on hand and free cash flow and executed via open-market and privately negotiated transactions, signals the board’s confidence in Abacus’s long-term business model, recurring earnings, and capital strength, while aiming to balance continued investment in growth, technology, and acquisitions with returning capital to shareholders.
The most recent analyst rating on (ABX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.
In a shareholder letter released on January 8, 2026, Abacus Global Management reported that 2025 was a defining year, highlighted by record third-quarter results with year-over-year revenue growth of 124%, adjusted net income growth of 60%, adjusted EBITDA growth of 127% with 60% margins, and 10 consecutive quarters of beating earnings expectations. The company raised its full-year 2025 adjusted net income guidance to $80–$84 million, reflecting 72%–81% growth and a higher earnings and cash-flow baseline, while advancing a strategic shift from largely transactional income toward a recurring revenue model—currently about 15% of revenue, with a long-term target of 70%—supported by assets under management rising to $3.33 billion and strengthened by the acquisition of digital life insurance platform AccuQuote and the introduction of a dividend and share repurchase program. Abacus underscored key milestones including the completion of a $50 million investment-grade securitized note backed by life insurance assets, which broadens institutional distribution and establishes a repeatable, lower-cost funding mechanism while generating ongoing servicing fees, and the planned 2026 launch of an asset-based finance investing strategy aimed at deploying third-party capital into asset-backed lending and structured credit, leveraging the firm’s actuarial expertise and insurance infrastructure in a market it estimates at more than $20 trillion. Management emphasized a robust balance sheet, record cash generation, and confidence that growth can be funded without additional equity issuance—implying no expected shareholder dilution—while also addressing the company’s valuation discount relative to faster-growing alternative asset management peers and outlining intensified investor outreach efforts designed to increase transparency, highlight fee-related earnings, and close the gap in market perception.
The most recent analyst rating on (ABX) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.